• 14087 Citations
  • 49 h-Index
1982 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jong-Seok Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 3 Scopus citations

    Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

    Ahn, M. J., Han, J. Y., Lee, K. H., Kim, S. W., Kim, D. W., Lee, Y. G., Cho, E. K., Kim, J. H., Lee, G. W., Lee, J. S., Min, Y. J., Kim, J. S., Lee, S. S., Kim, H. R., Hong, M. H., Ahn, J. S., Sun, J. M., Kim, H. T., Lee, D. H., Kim, S. & 1 others, Cho, B. C., Dec 2019, In : The Lancet Oncology. 20, 12, p. 1681-1690 10 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations
  • 79 Scopus citations

    Tissue and plasma EGFR mutation analysis in the FLAURA trial: Osimertinib versus Comparator EGFR tyrosine kinase inhibitor as first-line treatment in patients with EGFR-mutated advanced non–small cell lung cancer

    Gray, J. E., Okamoto, I., Sriuranpong, V., Vansteenkiste, J., Imamura, F., Lee, J. S., Pang, Y. K., Cobo, M., Kasahara, K., Cheng, Y., Nogami, N., Cho, E. K., Su, W. C., Zhang, G., Huang, X., Li-Sucholeiki, X., Lentrichia, B., Dearden, S., Jenkins, S., Saggese, M. & 2 others, Rukazenkov, Y. & Ramalingam, S. S., 15 Nov 2019, In : Clinical Cancer Research. 25, 22, p. 6644-6652 9 p.

    Research output: Contribution to journalArticle

  • 8 Scopus citations
    Open Access